about
Intravenous immunoglobulin, pharmacogenomics, and Kawasaki diseaseAn increase in reactive oxygen species by deregulation of ARNT enhances chemotherapeutic drug-induced cancer cell deathNovel Vitamin D Receptor Mutations in Hereditary Vitamin D Resistant Rickets in ChineseNo increased risk of herpes zoster found in cirrhotic patients: a nationwide population-based study in Taiwan.Genetic polymorphisms in Kawasaki disease.The influence of BMX gene polymorphisms on clinical symptoms after mild traumatic brain injuryComputational analysis of mRNA expression profiles identifies the ITG family and PIK3R3 as crucial genes for regulating triple negative breast cancer cell migrationA genetic polymorphism (rs17251221) in the calcium-sensing receptor gene (CASR) is associated with stone multiplicity in calcium nephrolithiasis.IL-31 associated with coronary artery lesion formation in Kawasaki diseasers10865331 associated with susceptibility and disease severity of ankylosing spondylitis in a Taiwanese population.Comparison of the laboratory data between Kawasaki disease and enterovirus after intravenous immunoglobulin treatment.Genetic polymorphisms of stromal interaction molecule 1 associated with the erythrocyte sedimentation rate and C-reactive protein in HLA-B27 positive ankylosing spondylitis patients.Association study of polymorphisms rs4552569 and rs17095830 and the risk of ankylosing spondylitis in a Taiwanese population.Sleep apnea and the risk of dementia: a population-based 5-year follow-up study in Taiwan.Close correlation between season of birth and the prevalence of bronchial asthma in a Taiwanese population.Single-nucleotide polymorphism rs7251246 in ITPKC is associated with susceptibility and coronary artery lesions in Kawasaki diseaseGenetic variants of CD209 associated with Kawasaki disease susceptibility.LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant ChemotherapySTIM1 overexpression promotes colorectal cancer progression, cell motility and COX-2 expression.Fascin protein is critical for transforming growth factor β protein-induced invasion and filopodia formation in spindle-shaped tumor cells.FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease.PTX3 gene activation in EGF-induced head and neck cancer cell metastasis.Interaction between HLA-B60 and HLA-B27 as a Better Predictor of Ankylosing Spondylitis in a Taiwanese PopulationAssociation Study between the FTCDNL1 (FONG) and Susceptibility to OsteoporosisStore-operated calcium channels and pro-inflammatory signals.Correlation of clinical features and genetic profiles of stromal interaction molecule 1 (STIM1) in colorectal cancers.Integrative bioinformatic analyses of an oncogenomic profile reveal the biology of endometrial cancer and guide drug discovery.Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease.rs657075 (CSF2) Is Associated with the Disease Phenotype (BAS-G) of Ankylosing SpondylitisStudy of the association between ITPKC genetic polymorphisms and calcium nephrolithiasis.Kawasaki disease: an update on diagnosis and treatment.Gene expression profiling combined with functional analysis identify integrin beta1 (ITGB1) as a potential prognosis biomarker in triple negative breast cancer.Identification of IGF-1-enhanced cytokine expressions targeted by miR-181d in glioblastomas via an integrative miRNA/mRNA regulatory network analysis.Involvement of L-type Ca²⁺ channel and toll-like receptor-4 in nickel-induced interleukin-8 gene expression.MicroRNA-302b-inhibited E2F3 transcription factor is related to all trans retinoic acid-induced glioma cell apoptosis.Local Ca2+ influx through Ca2+ release-activated Ca2+ (CRAC) channels stimulates production of an intracellular messenger and an intercellular pro-inflammatory signal.All-or-none activation of CRAC channels by agonist elicits graded responses in populations of mast cells.Ca2+ influx through CRAC channels activates cytosolic phospholipase A2, leukotriene C4 secretion, and expression of c-fos through ERK-dependent and -independent pathways in mast cells.Close functional coupling between Ca2+ release-activated Ca2+ channels, arachidonic acid release, and leukotriene C4 secretion.Associations of genetic variants of endothelin with cardiovascular complications in patients with renal failure.
P50
Q26865524-A0DA411C-4C66-40F6-B4A5-05945094E758Q28539641-3B9E883D-46E6-42C6-B2F6-BA281BF50B08Q28548633-C0CD9470-9DF9-4A98-9238-B91809970AECQ31156767-51A9AEDD-8C6A-492A-B7E2-6C756E44D190Q33566136-28CA4A3F-384E-4EB2-9D8C-516C3901E85FQ33594287-C084D3D8-2674-4695-91AB-E5E21B19EF99Q33657062-6176C57C-46F6-45DD-B5FB-DE73FF64C2DCQ34038091-B6495013-EDA4-451B-9F41-5A2C1725E841Q34047318-BFC21265-B19E-4847-9EFC-D53F1A5FC877Q34128240-DDBDEAC4-CD81-4D00-967D-3FB6ADA1CDDBQ34207898-5A55D3F7-B72F-4550-A339-FA6C53EB862AQ34524880-BD54A786-6178-4AF6-8348-90D4E63F01CBQ34544569-D6C347C5-0FA4-408C-AF61-814676A7A153Q35036622-40055592-3560-4002-9A97-075A7702FAD9Q35053535-58FBF783-DC79-4BBB-A045-B201DF59CDE0Q35118611-90DAE85A-33BF-4F7A-BCEC-0FD263028211Q35229960-C0EC26C6-F644-43AE-B7C0-1C798E9549DEQ35547217-645CA028-460C-4030-93E9-9082E783E82FQ35589595-109DFE4D-18F7-4473-8A4F-979BFB266A0BQ35604194-1C06AA97-4B91-4C8E-B551-56C469F7457CQ35673684-978EB273-D56D-4E25-8720-CB854A5B50C0Q35781404-5B84B2DF-FFF1-496C-A9DA-163B83080A38Q35808744-A92F774D-2881-4101-A51F-58EE8C61C469Q35817451-384778F3-6ECA-489E-A344-FE44D7A7E99CQ36513347-F7BB2091-637A-42B4-8DD3-7BE60B94BD21Q36561714-6618A215-73D0-4124-BB3D-55857BA74B7CQ36905799-DAC63D10-028E-4E23-B7F6-31C4AAA34385Q37206453-C5359489-0B70-4088-9F4E-DC7A16A49AACQ37631508-3772D9C8-200D-4CF5-8F7A-8E4F717BF572Q37706439-986DE5A8-8295-48CB-BA3C-3150AD955CDDQ37986163-5E81D099-DD9E-43D3-83C1-8063D3D79CDEQ38811290-B28656E2-13A3-4812-8BBA-15F5721619ECQ38847110-CDB4AAD4-B359-4689-8C99-96457ED8B49CQ38973404-0341C00F-79AA-469D-9E31-5083EC0179DCQ38973972-8F1F8D76-B4DD-48BB-8361-9D32F9E01EB5Q40031559-46AA0396-06C2-4EAA-90CA-6F2976AD5A72Q40073072-92AEC4A2-3326-4E45-93F8-92068646C510Q40223227-98D2959A-9ED0-4D96-929D-98C331F7D37AQ40558079-8FF1C628-DA7F-4FAE-BF1F-E0D46BAD771BQ41522985-A18E0F06-A2C1-4526-8970-67B60976D9F9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Wei-Chiao Chang
@ast
Wei-Chiao Chang
@en
Wei-Chiao Chang
@es
Wei-Chiao Chang
@nl
type
label
Wei-Chiao Chang
@ast
Wei-Chiao Chang
@en
Wei-Chiao Chang
@es
Wei-Chiao Chang
@nl
prefLabel
Wei-Chiao Chang
@ast
Wei-Chiao Chang
@en
Wei-Chiao Chang
@es
Wei-Chiao Chang
@nl
P106
P31
P496
0000-0002-8573-5924